Effect of Short-Term Erythropoietin Therapy on Insulin Resistance in Diabetic and Non-Diabetic Hemodialysis Patients | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 1, Issue 1, October 2021 PDF (75.14 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2021.455579 | ||
| Abstract | ||
| Insulin resistance (IR) is a frequent multifactorial complication of uremia. It is considered an independent predictor for cardiovascular events and mortality in patients with chronic kidney disease (CKD); it may be an important therapeutic target in management of CKD. The study was conducted to evaluate the effect of short-term treatment with recombinant human erythropoietin (rHuEpo) therapy on IR, in diabetic and non-diabetic end stage renal disease (ESRD) patients on hemodialysis. | ||
|
Statistics Article View: 18 PDF Download: 4 |
||
